Motor Cortex Stimulation in Chronic Neuropathic Orofacial Pain
Abstract
Motor cortex stimulation (MCS) has been used to treat intractable neuropathic facial pain lasted for early 30 years. Although
in some studies the effective rate is as high as 88%, it is quite impressive the variability of treatment response. In addition,
MCS is generally considered to gradually reduce remission over time, and there are few long-term studies on efficacy. Complications are generally mild including infections, hardware complications, seizures and transient neurological deficits. Although
relatively rarely u
References
Guzzi, G., Della Torre, A., Colica, C., Marianna, LS., Vescio, G., Giorgio, V., et al. (2015) Motor Cortex Stimulation for Chronic Central and Peripheral Neuropathic Pain: State of Art. J Pain Relief, 4: 219.
Penfield, W., Jasper, H. (1954) Epilepsy and the Functional Anatomy of the Human Brain. Boston, Little, Brown and Co.
Lende, RA., Kirsch, WM., Druckman, R. (1971) Relief of facial pain after combined removal of precentral and postcentral cortex. J Neurosurg, 34(4): 537–543.
Tsubokawa, T., Katayama, Y., Yamamoto, T., Hirayama, T., Koyama, S. (1991) Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl (Wien), 52: 137–139.
Nuti, C., Peyron, R., Garcia-Larrea, L., Brunon, J., Laurent, B., Sindou, M., et al. (2005) Motor cortex stimulation for refractory neuropathic pain: four year outcome and predictors of efficacy. Pain, 118(1-2): 43–52.
Raslan, AM., Nasseri, M., Bahgat, D., Abdu, E., Burchiel, KJ. (2011) Motor cortex stimulation for trigeminal neuropathic or deafferentation pain: an institutional case series experience. Stereotact Funct Neurosurg, 89(2): 83–88.
Merlo, L., Cimino, F., Angileri, FF., La Torre, D., Conti, A., Cardali, SM., et al. (2014) Alteration in synaptic junction proteins following traumatic brain injury. J Neurotrauma, 31(16): 1375-1385.
Slavin, KV. (2020) Neuromodulation for Facial Pain. Prog Neurol Surg. Basel, Karger, 35: 170–180.
Levine, DA., Argoff, CE., Pilitsis, J. (2014) Trigeminal neuropathic pain and anesthesia dolorosa; in Burchiel KJ (ed): Surgical Management of Pain, (2ndedn), New York, Thieme, 180–190.
Peyron, R., Garcia-Larrea, L., Deiber, MP., Cinotti, L., Convers, P., Sindou, M., et al. (1995) Electrical stimulation of precentral cortical area in the treatment of central pain: electrophysiological and PET study. Pain, 62(3): 275–286.
Garcia-Larrea, L., Peyron, R., Mertens, P., Gregoire, MC., Lavenne, F., Bonnefoi, F., et al. (1997) Positron emission tomography during motor cortex stimulation for pain control. Stereotact Funct Neurosurg, 68: 141–148.
Garcia-Larrea, L., Peyron, R., Mertens, P., Laurent, B., Mauguiere, F., Sindou, M. (2000) Functional imaging and neurophysiological assessment of spinal and brain therapeutic modulation in humans. Arch Med Res, 31(3): 248–257.
Henssen, D., Kurt, E., van Walsum, AVC., Kozicz, T., van Dongen, R., Bartels, R. (2020) Motor cortex stimulation in chronic neuropathic orofacial pain syndromes: a systematic review and meta-analysis. Sci Rep, 10(1): 7195.
Brown, JA., Pilitsis, JG. (2005) Motor cortex stimulation for central and neuropathic facial pain: a prospective study of 10 patients and observations of enhanced sensory and motor function during stimulation. Neurosurgery, 56(2): 290-297.
Fontaine, D., Hamani, C., Lozano, A. (2009) Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg, 110(2): 251-256.
Henderson, JM., Boongird, A., Rosenow, JM., LaPresto, E., Rezai, AR. (2004) Recovery of pain control by intensive reprogramming after loss of benefit from motor cortex stimulation for neuropathic pain. Stereotact Funct Neurosurg, 82(5-6): 207-213.
Deer, TR., Mekhail, N., Petersen, E., Krames, E., Staats, P., Pope, J., et al. (2014) Neuromodulation Appropriateness Consensus Committee. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation, 17(6): 551-570.
